Jeffrey H. Cooper

This profile gathers the share dealings of Jeffrey H. Cooper in Biomarin Pharmaceutical Inc. Between 27 February 2006 and 14 May 2012, the trades on record add up to 135 filings.

Both buying and selling appear: 1 purchase worth €9,555, against 78 sales worth €9.7M. The net balance comes to €9.7M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 share grants and 45 option exercises. So far in 2012, the count stands at no purchases and 3 sales.

The record was last updated on 16 May 2012 with a share grant (€14k) in Biomarin Pharmaceutical Inc. The clock since the last published purchase (8 July 2008) now reads 6,697 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.